CompletedNot Applicable

Corneal Epithelial Stem Cells and Dry Eye Disease

United States17 participantsStarted 2019-02-01

Plain-language summary

To study of a novel, therapeutic Human Cells, Tissues, and Cellular and Tissue-Based Product (HCT/P) in the treatment of severe dry eye disease that is failing conventional treatments. This pilot study will carefully observe and monitor each qualifying and willing individual for response to treatment, signs of toxicity and adverse effects from the treatment, and for ability of the treatment to improve comfort and restore vision.

Who can participate

Age range18 Years – 100 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Clinical diagnosis of advanced dry eye disease * Severe dry eye symptoms despite having tried over a half dozen treatments Exclusion Criteria: * Not willing to undergo clinical trial * Unable to comply with treatment regimen

What they're measuring

Ocular Surface Disease Index (OSDI)

Timeframe: 3 months

Trial details

NCT IDNCT03302273

SponsorSloan W. Rush, MD

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-04-01

View on ClinicalTrials.gov More Dry Eye Syndromes trials